quisqualic acid has been researched along with Neuralgia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, JG; Erasso, D; Levitt, RC; Tender, G | 1 |
Eaton, MJ; Wolfe, SQ | 1 |
Cumberbatch, N; Eaton, M; Martinez, M; Menendez, I; Quintero Wolfe, SC | 1 |
3 other study(ies) available for quisqualic acid and Neuralgia
Article | Year |
---|---|
Agrin requires specific proteins to selectively activate γ-aminobutyric acid neurons for pain suppression.
Topics: Adenoviridae; Agrin; Animals; Disease Models, Animal; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Gene Expression Regulation; Hyperalgesia; Injections, Spinal; Male; Molecular Weight; Neuralgia; Pain Measurement; Pain Threshold; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Time Factors | 2014 |
Clinical feasibility for cell therapy using human neuronal cell line to treat neuropathic behavioral hypersensitivity following spinal cord injury in rats.
Topics: Animals; Behavior, Animal; Cell Line; Cell- and Tissue-Based Therapy; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glycine; Humans; Immunohistochemistry; Neuralgia; Neurons; Quisqualic Acid; Rats; Rats, Inbred WF; Spinal Cord; Spinal Cord Injuries | 2009 |
Ronald Tasker Award: Intrathecal transplantation of a human neuronal cell line for the treatment of neuropathic pain in a spinal cord injury model.
Topics: Animals; Carcinoma, Embryonal; Cell Line, Tumor; gamma-Aminobutyric Acid; Glycine; Injections, Spinal; Male; Nerve Regeneration; Neuralgia; Neurons; Pain; Pain Threshold; Quisqualic Acid; Rats; Rats, Inbred WF; Spinal Cord; Spinal Cord Injuries; Vesicular Inhibitory Amino Acid Transport Proteins | 2007 |